Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVa [clinicaltrials:NCT02153255]
Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVa [clinicaltrials:NCT02153255]
Bio2RDF identifier
NCT02153255
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT02153255
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Mucopolysaccharidosis T ...... hildren with MPS IVa to walk.
brief title [clinicaltrials_vocabulary:brief-title]
Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVa
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2017-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2014-05-28T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Galactosamine-6-Sulfatase
Mucopolysaccharidosis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-01-26T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT02153255
number of arms [clinicaltrials_vocabulary:number-of-arms]
org study id [clinicaltrials_vocabulary:org-study-id]
14/WM/0120
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2016-07-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2015-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-01-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Closure of Gait Analysis Labor ...... then recruitment will commence
identifier
clinicaltrials:NCT02153255
title
Dynamic Gait Analysis in Children With Mucopolysaccharidosis Type IVa
@en
type
label
Dynamic Gait Analysis in Child ...... a [clinicaltrials:NCT02153255]
@en